Analysis of Glasgow Prognostic Score(GPS) in KRAS EXON2 Wild Type Patients with Metastatic Colorectal Cancer (MCRC) Treated with Salvage-Line Cetuximab-Based Regimen: HGCSG0901
Titel:
Analysis of Glasgow Prognostic Score(GPS) in KRAS EXON2 Wild Type Patients with Metastatic Colorectal Cancer (MCRC) Treated with Salvage-Line Cetuximab-Based Regimen: HGCSG0901